Cargando…
The RET C611Y mutation causes MEN 2A and associated cutaneous lichen amyloidosis
BACKGROUND: Cutaneous lichen amyloidosis (CLA) has been reported in some multiple endocrine neoplasia type 2A (MEN 2A) families affected by specific germline RET mutations C634F/G/R/W/Y or V804M, as a characteristic of the clinical manifestation in ‘MEN 2A with CLA’, one of four variants of MEN 2A,...
Autores principales: | Qi, Xiao-Ping, Peng, Jian-Zhong, Yang, Xiao-Wei, Cao, Zhi-Lie, Yu, Xiu-Hua, Fang, Xu-Dong, Zhang, Da-Hong, Zhao, Jian-Qiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176283/ https://www.ncbi.nlm.nih.gov/pubmed/30300539 http://dx.doi.org/10.1530/EC-18-0220 |
Ejemplares similares
-
Rare manifestation of multiple endocrine neoplasia type 2A & cutaneous lichen amyloidosis in a family with RET gene mutation
por: Birla, Shweta, et al.
Publicado: (2014) -
Multiple endocrine neoplasia 2A with RET mutation p.Cys611Tyr: A case report
por: Li, Yan, et al.
Publicado: (2021) -
RET mutation p.S891A in a Chinese family with familial medullary thyroid carcinoma and associated cutaneous amyloidosis binding OSMR variant p.G513D
por: Qi, Xiao-Ping, et al.
Publicado: (2015) -
Primary localized cutaneous amyloidosis with lichen and
poikiloderma-like lesions and an excellent response to systemic acitretin
por: MA, Han, et al.
Publicado: (2016) -
Response to oral acitretin in lichen amyloidosis
por: Vasani, Resham J.
Publicado: (2014)